These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3501756

  • 1. In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
    Hiraoka M, Masuyoshi S, Tomatsu K, Inoue M, Mitsuhashi S.
    Eur J Clin Microbiol; 1987 Oct; 6(5):559-63. PubMed ID: 3501756
    [Abstract] [Full Text] [Related]

  • 2. BMY 28100, a new oral cephalosporin.
    Leitner F, Pursiano TA, Buck RE, Tsai YH, Chisholm DR, Misiek M, Desiderio JV, Kessler RE.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
    Matsui H, Hiraoka M, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):555-61. PubMed ID: 2344162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ, Washington JA.
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
    Inoue E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
    Verbist L, Jacobs J, Hens K.
    Diagn Microbiol Infect Dis; 1991 Sep; 14(1):53-61. PubMed ID: 1901535
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of BAY v 3522, a new oral cephalosporin.
    Fass RJ.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV, Vautour R.
    Diagn Microbiol Infect Dis; 1992 Sep; 15(7):633-40. PubMed ID: 1424521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.